NSB
Click for more information
5.26% 4.0¢ neuroscientific biopharmaceuticals ltd

Ann: Ethics Approval Granted for Early-Phase Clinical Trial, page-34

  1. wolfofall
    826 Posts.
    lightbulb Created with Sketch. 189
    clock Created with Sketch.
    16/06/22
    21:06
    Post #: 62044285
    the results were positive, certainly didn't double... or are you referring to upcoming trials?
    NSB Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
4.0¢ 		Change
0.002(5.26%) 		Mkt cap ! $5.784M
Open High Low Value Volume
3.8¢ 4.0¢ 3.8¢ $2.873K 73.50K

Buyers (Bids)

No. Vol. Price($)
2 73916 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 99999 1
View Market Depth
Last trade - 16.10pm 04/07/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.